VIGLN_CHICK
ID VIGLN_CHICK Reviewed; 1270 AA.
AC P81021;
DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1997, sequence version 1.
DT 03-AUG-2022, entry version 102.
DE RecName: Full=Vigilin;
GN Name=HDLBP; Synonyms=VGL;
OS Gallus gallus (Chicken).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC Phasianinae; Gallus.
OX NCBI_TaxID=9031;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Embryonic sternal cartilage;
RX PubMed=1606952; DOI=10.1111/j.1432-1033.1992.tb16967.x;
RA Schmidt C., Henkel B., Poeschl E., Zorbas H., Purschke W.G., Gloe T.R.,
RA Mueller P.K.;
RT "Complete cDNA sequence of chicken vigilin, a novel protein with amplified
RT and evolutionary conserved domains.";
RL Eur. J. Biochem. 206:625-634(1992).
CC -!- SUBCELLULAR LOCATION: Cytoplasm.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X65292; CAA46387.1; -; mRNA.
DR PIR; S23464; S23464.
DR AlphaFoldDB; P81021; -.
DR SMR; P81021; -.
DR STRING; 9031.ENSGALP00000009341; -.
DR PaxDb; P81021; -.
DR PRIDE; P81021; -.
DR VEuPathDB; HostDB:geneid_395984; -.
DR eggNOG; KOG2208; Eukaryota.
DR InParanoid; P81021; -.
DR PhylomeDB; P81021; -.
DR Proteomes; UP000000539; Unplaced.
DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR GO; GO:0005844; C:polysome; IBA:GO_Central.
DR GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR Gene3D; 3.30.1370.10; -; 13.
DR InterPro; IPR004087; KH_dom.
DR InterPro; IPR004088; KH_dom_type_1.
DR InterPro; IPR036612; KH_dom_type_1_sf.
DR Pfam; PF00013; KH_1; 14.
DR SMART; SM00322; KH; 14.
DR SUPFAM; SSF54791; SSF54791; 14.
DR PROSITE; PS50084; KH_TYPE_1; 14.
PE 2: Evidence at transcript level;
KW Cytoplasm; Reference proteome; Repeat; RNA-binding.
FT CHAIN 1..1270
FT /note="Vigilin"
FT /id="PRO_0000050134"
FT DOMAIN 150..188
FT /note="KH 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 219..260
FT /note="KH 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 291..333
FT /note="KH 3"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 360..402
FT /note="KH 4"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 431..473
FT /note="KH 5"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 504..545
FT /note="KH 6"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 577..619
FT /note="KH 7"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 651..693
FT /note="KH 8"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 724..766
FT /note="KH 9"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 798..840
FT /note="KH 10"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 872..913
FT /note="KH 11"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 970..1012
FT /note="KH 12"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 1051..1093
FT /note="KH 13"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT DOMAIN 1126..1168
FT /note="KH 14"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT REGION 1..23
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 28..47
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 911..947
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1217..1270
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 929..947
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1270 AA; 142221 MW; 0A8844F91F9B8619 CRC64;
MSSVAVLTQE SFAEHRSGLT QQQVKVTALN SEEENDPPTY KEAFPPLPEK APCLEAAQEP
SGPWSKIRPI KASVITQVFH VPLEERKYKD MNQFGEGEQA KICLDIMQKT GAHLELSLAK
DQGLSIMVSG KLEAVMKARK EIVARLQTQA SATVAIPKEH HRFVIGKNGE KLQDLELKTA
TKIQIPRPDD PSNQIKITGT KEGIEKARHE ILLISAEQDK RAVERLDVEK VYHPFIAGPY
NKLVSELMQD TGTRINIPPP SVNKTEIVFT GEKEQLAQAV ARVKKIYEEK KKKTTTIAVE
VKKSQHKYVI GRKGNSLQEI LEKTGVSVEI PPTDSSSETV ILRGEPEKLG QALTEVYAKA
NSFTVSSVSA PSWLHRFIIG LFGQNLAKIT QQMPKIHIEF TEGEDKITSE GPTEDVNVAQ
EQIEVMVKDL INRTDYAEIN VDHKFHRHLI GKNGANINRI KDLYKVSVRI PPDNEKSNLI
RIEGDPQGVQ QAKKELLELA SRMENERTKD LIIEQKFHRT IIGQKGERIR EIREKFPEVI
INFPDPAHKS DIVQLRGPKN EVEKCTKYMQ KMVADLVENS FSISVPIFKQ FHKNIIGKGG
ANIKKIREES NTKIDLPGRE QATQRQLLSQ GREQTVKLLR HRILAIQKEL ANITEVEVSI
PSKLHNSLIG AKGRFIRSIM EECGGVHIHF PTEGSGSATV TIRAQPRTWR KPRSSCCTWA
EEKQTKSYTV DLRAKPEYHK FLIGKGGGNI RKVRDNTGAR IIFPTSEDKD QELITIMGTE
EAVKEAQKEL EALIKNLDNV VEDSMVVDPK HHRHFVIRRG QVLREIADEY GGVMVRLPTV
SGTQSDKVTL KGAKDCVEAA KKRIQEIIED LEAQVTIECT IPQKFHRSIM GPKGSRIQQI
TRDYGVQIKF PDREENPAPV AEPALQENGE EGGEGKDGKD ADPSSPRKCD IIIISGRREK
CEAAKEALQA LVPVTIEVEV PFDLHRYIIG QKGSGIRKMM DEFEVNIQVP APELQSSDII
TITGLAANLD RAKAGLLERV KELQAEQEDR ALRSFKLTVT VDPKYHPKII GRKGAVITQI
RTEHEVNIQF PDKDDESQAQ DQITITGYEK NAEAARDAIM KIVGELEQMV SEDVTLDHRV
HARIIGARGK AIRKIMDEFK VDIRFPQSGA PDPNCVTVTG LPENVEEAID HILNLEEEYL
ADVVDNEAMQ VYMKPSSHEE SKVPSKGFVV RDAPCGTVNN EKAPDMSSSE DFPSFGAQVA
PKTLPWGPKR